Literature DB >> 25860288

Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review.

Christian Manzardo1, Alberto C Guardo, Emilio Letang, Montserrat Plana, Jose M Gatell, Jose M Miro.   

Abstract

Despite the availability of effective combined antiretroviral treatment, many patients still present with advanced HIV infection, often accompanied by an AIDS-defining disease. A subgroup of patients starting antiretroviral treatment under these clinical conditions may experience paradoxical worsening of their disease as a result of an exaggerated immune response towards an active (but also subclinical) infectious agent, despite an appropriate virological and immunological response to the treatment. This clinical condition, known as immune reconstitution inflammatory syndrome, may cause significant morbidity and even mortality if it is not promptly recognized and treated. This review updates current knowledge about the incidence, diagnostic criteria, risk factors, clinical manifestations, and management of opportunistic infections and immune reconstitution inflammatory syndrome in the combined antiretroviral treatment era.

Entities:  

Keywords:  AIDS-defining diseases; IRIS definition; IRIS incidence; IRIS management; IRIS treatment; Kaposi sarcoma; TB; combined antiretroviral therapy; immune reconstitution inflammatory syndrome; opportunistic infections

Mesh:

Year:  2015        PMID: 25860288     DOI: 10.1586/14787210.2015.1029917

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  15 in total

1.  Immune Reconstitution Inflammatory Syndrome Presenting as Mycobacterium Avium Complex Lymphadenitis.

Authors:  Ashley Matusz-Fisher; Wesley Bodie; Thomas Montgomery
Journal:  J Gen Intern Med       Date:  2016-12-20       Impact factor: 5.128

2.  Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.

Authors:  Huldrych F Günthard; Michael S Saag; Constance A Benson; Carlos del Rio; Joseph J Eron; Joel E Gallant; Jennifer F Hoy; Michael J Mugavero; Paul E Sax; Melanie A Thompson; Rajesh T Gandhi; Raphael J Landovitz; Davey M Smith; Donna M Jacobsen; Paul A Volberding
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

3.  Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report.

Authors:  M E Gatti-Mays; M Manion; L N Bowen; G T Brown; R L Danner; O Khan; A Nath; M Battiwalla; A J Barrett; S Ito
Journal:  Bone Marrow Transplant       Date:  2016-09-19       Impact factor: 5.483

4.  Cardiovascular Biomarker Profile on Antiretroviral Therapy Is Not Influenced by History of an IRIS Event in People With HIV and Suppressed Viremia.

Authors:  Aurelie Gouel-Cheron; Martha Nason; Adam Rupert; Virginia Sheikh; Greg Robby; Gary A Fahle; Irini Sereti
Journal:  Open Forum Infect Dis       Date:  2020-01-11       Impact factor: 3.835

5.  Toxoplasmosis-associated IRIS involving the CNS: a case report with longitudinal analysis of T cell subsets.

Authors:  Rita Rb-Silva; Claudia Nobrega; Eugénia Reiriz; Soraia Almeida; Rui Sarmento-Castro; Margarida Correia-Neves; Ana Horta
Journal:  BMC Infect Dis       Date:  2017-01-13       Impact factor: 3.090

6.  Ordering Patterns and Costs of Specialized Laboratory Testing by Hospitalists and House Staff in Hospitalized Patients With HIV at a County Hospital: An Opportunity for Diagnostic Stewardship.

Authors:  Kathryn Bolles; Laila Woc-Colburn; Richard J Hamill; Vagish Hemmige
Journal:  Open Forum Infect Dis       Date:  2019-03-29       Impact factor: 3.835

Review 7.  HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease.

Authors:  José Ernesto Vidal
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

Review 8.  Management of HIV-infected patients in the intensive care unit.

Authors:  François Barbier; Mervin Mer; Piotr Szychowiak; Robert F Miller; Éric Mariotte; Lionel Galicier; Lila Bouadma; Pierre Tattevin; Élie Azoulay
Journal:  Intensive Care Med       Date:  2020-02-03       Impact factor: 17.440

9.  Pleuropulmonary Kaposi Sarcoma in the Setting of Immune Reactivation.

Authors:  Karthik Suresh; Roy Semaan; Sixto Arias; Petros Karakousis; Hans Lee
Journal:  J Pulm Respir Med       Date:  2016-05-30

Review 10.  Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research.

Authors:  Andrew Levine; Ned Sacktor; James T Becker
Journal:  J Neurovirol       Date:  2020-09-03       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.